Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013

J Clin Microbiol. 2014 Jul;52(7):2644-6. doi: 10.1128/JCM.00362-14. Epub 2014 Apr 23.

Abstract

From 2002 to 2013 in Montreal, Quebec, Canada, 38 Campylobacter coli isolates were more frequently erythromycin, tetracycline, and ciprofloxacin resistant than 440 Campylobacter jejuni subsp. jejuni isolates (18.4% versus 1.8%; P = 0.00005), of which the 148 isolates acquired abroad were more frequently erythromycin, tetracycline, and ciprofloxacin resistant than the 292 isolates acquired locally (5.4% versus 0%; P = 0.0001).

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Campylobacter Infections / microbiology
  • Campylobacter coli / drug effects*
  • Campylobacter coli / isolation & purification
  • Campylobacter jejuni / drug effects*
  • Campylobacter jejuni / isolation & purification
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Bacterial*
  • Erythromycin / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Quebec
  • Tetracycline / pharmacology

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Erythromycin
  • Tetracycline